Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity

NCT04750356 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT04750356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04750356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity
Lead sponsor
University College, London
Phase
Observational
Overall status
Unknown status
Start date
January 27, 2021
Completion date
December 31, 2024
Enrollment
6,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov infection